Heartfelt thanks to Hon'ble @MinisterKTR & all our esteemed dignitaries for gracing the groundbreaking ceremony of our expansion in @GenomeValley, #Hyderabad. Your presence made it an unforgettable success as we continue to drive innovation & growth in #biotech & #lifesciences!
Watch the groundbreaking ceremony at Genome Valley, Hyderabad, India.
#puttingsciencetowork
watch video on watch page
0 - 0
Today on International Day of Women and Girls in Science, we celebrate the efforts and achievements of our women scientists at Syngene and around the world. Despite facing numerous obstacles, their constant efforts in research and innovation help improve lives and transform the world we live in.
As we take this moment to thank them, share with us some of the #WomenInScience that inspire you!π©βπ¬
πHere are a few of our #WomenInScience sharing their stories and #LifeAtSygnene.
β¦Ώ Dr. Jayashree Aiyar - VP & Head of Discovery Biology
π https://youtu.be/8q8qaMbs9Dk
β¦Ώ Dr. Aparna Kasinath - Head, Regulated Large Molecule, Bioanalytical Laboratory
π https://youtu.be/MkdWojqBqCg
β¦Ώ Sarah Chatterjee - Global Business Development Manager
π https://youtu.be/175mh3BsOJQ
#GirlsInScience #IDWGS2023
6 - 1
In celebration of Biocon foundation day, a science fair for school children and a health camp for the elderly were held in our local communities in Bangalore. In association with the group CSR arm, Biocon Foundation, these CSR events were organized as a tribute to late John Shaw, former vice chairman of the Biocon and former board member of Syngene.
#Science #health #wellbeing #CSR
6 - 0
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq.ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com
27 November 2015